Endovascular Abdominal Aortic Aneurysm Repair Devices Market Size is valued at USD 2.43 Bn in 2023 and is predicted to reach USD 3.53 Bn by the year 2031 at a 4.9% CAGR during the forecast period for 2024-2031.
Endovascular abdominal aortic aneurysm (AAA) repair devices are minimally invasive tools designed to treat abdominal aortic aneurysms. These devices, primarily stent grafts, are inserted into the weakened section of the aorta via small incisions in the groin using catheters. The stent graft, a fabric tube supported by a metal mesh, reinforces the aortic wall, preventing the aneurysm from rupturing. The procedure is guided by advanced imaging techniques for precise placement. Favourable reimbursement policies and increasing healthcare expenditure in developing regions further propel market expansion. However, challenges like high treatment costs and limited access to advanced healthcare facilities may hinder market growth in some regions. Nonetheless, key players' strategic collaborations and product innovations are expected to sustain market growth.
The COVID-19 pandemic significantly impacted the Endovascular Abdominal Aortic Aneurysm Repair Devices Market. Elective procedures faced postponements due to healthcare facility prioritization for COVID-19 patients and reduced patient visits. Supply chain disruptions and logistical challenges hindered the availability of devices. However, increased adoption of telemedicine facilitated pre-operative consultations and post-operative care, partially mitigating the impact. Moreover, the market witnessed a gradual recovery with the resumption of elective surgeries and the implementation of stringent safety protocols in healthcare settings. Despite initial setbacks, the market is anticipated to rebound as healthcare systems adapt to the new normal and address the backlog of postponed procedures.
Competitive Landscape
Some Major Key Players In The Endovascular Abdominal Aortic Aneurysm Repair Devices Market:
- Terumo Medical Corporation
- Medtronic Plc
- Becton Dickinson and Company
- Koninklijke Philips N.V.
- Lombard Medical Inc.
- Endologix Inc.
- Abbott Laboratories
- Cardinal Health Inc.
- L. Gore & Associates Inc
- Boston Scientific Corporation
- Cook Group Incorporated
- Other Prominent Players
Market Segmentation:
The market is segmented by product type, age group, material, aortic length and end-user. By product type, the market is divided into Synthetic Fabric Graft, Stent-graft. According to age group, this market is categorized into Adult, Geriatric, and Pediatric. The material segment comprises Polymer and Metal. As per the Aortic Length, the market consists of Above 50 mm and Above 100 mm. Lastly, the end-user segment is categorized into hospitals, ambulatory surgical centres (ASCs), research institutes, and others.
Based On Product Type, The Endovascular Stent Graft System Segment Is A Major Contributor To The Endovascular Abdominal Aortic Aneurysm Repair Devices Market.
Stent grafts are a dominant product segment in the global endovascular AAA repair devices market, which is expanding rapidly. The ageing population and growing demand for less invasive endovascular therapies drive the demand for abdominal aortic aneurysm devices. Because they are less intrusive, stent-grafts provide patients with better outcomes, shorter hospital stays, and quicker recovery times than open surgical treatments. The extensive use of stent grafts in abdominal aortic aneurysm repair surgeries globally is supported by favourable reimbursement policies, improvements in imaging, and interventional techniques.
The Hospital Segment Based On Application Also Witnessed Rapid Growth.
The hospital segment was valued as the most significant share based on application. Hospitals can complete these complex treatments because of their state-of-the-art healthcare infrastructure and qualified medical staff. Hospitals are more likely to accept patients for endovascular abdominal aortic aneurysm repair due to increased awareness among patients and healthcare professionals about its benefits. Hospital adoption of endovascular abdominal aortic aneurysm repair devices is expected to increase.
In This Market, North America Has A Significant Revenue Share.
North America's Endovascular Abdominal Aortic Aneurysm Repair Devices Market boasts the highest market share for several reasons. North America is expected to witness lucrative growth due to increased incidence of chronic diseases—countries like the U.S. focus on well-established healthcare infrastructure with advanced technological support, including sports medicine. The participation of major market players in this region has increased production capacities. In addition, the rising popularity of sports in this region is crucial in the market growth. The market in Asia Pacific is expected to experience moderate growth due to the high demand for point-of-care testing. Additionally, the rise in the incidence of diabetes in countries such as China and India has led to an increase in sales of lactometers. Europe's market is projected to grow steadily due to a surge in awareness about early diagnosis and treatment of chronic diseases.
Recent Developments
- In Jan 2023, Medtronic has initiated the first phase of a worldwide randomized trial to assess the long-term effectiveness of endovascular aneurysm repair. The ADVANCE Trial was a worldwide, post-market, forward-looking, interventional, multicenter, randomized research that recruited at least 550 participants at a maximum of 50 locations around the world.
- In Oct 2021, Terumo Aortic has received regulatory approval and has officially launched the Treo abdominal aortic stent transplant system in Japan. The Treo device has been authorized by the Japanese Pharmaceuticals & Medical Devices Agency for the treatment of individuals suffering from abdominal aortic aneurysms.
Endovascular Abdominal Aortic Aneurysm Repair Devices Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 2.43 Bn |
|
Revenue Forecast In 2031 |
USD 3.53 Bn |
|
Growth Rate CAGR |
CAGR of 4.9 % from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product Type, Age Group, Material, Aortic Length And End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Terumo Medical Corporation, Medtronic Plc, Becton, Dickinson and Company, Koninklijke Philips N.V., Lombard Medical Inc, Cook Medical, Endologix Inc, Abbott Laboratories, Cardinal Health Inc, W. L. Gore & Associates Inc., Boston Scientific Corporation, Cook Group Incorporated, Other Prominent Players |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
